Navigation Links
TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Date:12/10/2007

Final Data from Pivotal Study Presented at 49th American Society of

Hematology Meeting

FRAZER, Pa., Dec. 10 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that in a pivotal study of patients with indolent non-Hodgkin's lymphoma (NHL), whose disease has progressed during or following treatment with rituximab, TREANDA (bendamustine HCl) induced a high rate of response. TREANDA(R) is a novel investigational chemotherapy. According to the National Cancer Institute, an estimated 30,000 people in the United States will be diagnosed in 2007 with indolent NHL, a serious and slow growing cancer of the lymphatic system that is difficult to treat because patients are prone to relapse after treatment. The final data from this multicenter study were presented at the 49th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, GA [Poster # 505-I; Abstract #1351].

"The high response rate in this study suggest that bendamustine could offer substantial periods of remission to patients with indolent NHL whose cancer is progressing after treatment with rituximab," said Brad Kahl, MD, Associate Professor, Director Lymphoma Service, University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, and the lead investigator of this study. "Because many patients with NHL eventually become resistant to treatment with rituximab and other therapies, new treatments are always required."

In this pivotal study of 100 patients with indolent NHL whose disease has progressed during or following treatment with rituximab, or a rituximab- containing regimen, as assessed by an independent radiological committee, 75 patients had a response. Of those patients who responded to treatment, 14 had a complete response and three had an unconfirmed complete response. The median duration of response was 9.2 months. Bendamustine demonstrated a manageable tolerability profile. As would be expected of a chemothera
'/>"/>

SOURCE Cephalon Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
2. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
3. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
5. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
6. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
7. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
8. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
9. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
10. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
11. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... HILL, N.C. , Sept. 19, 2014 /PRNewswire/ ... role in forging relationships with key opinion leaders ... market and competition. Despite the critical nature of ... created many challenges, including altering the landscape for ... According to research, the oversight responsibility ...
(Date:9/19/2014)... , Sept. 19, 2014 A pharmaceutical executive ... LLC with three issues he wanted the research and ... of external personnel (especially for secondary research) to maximize ... face of increased workload , Automation of market ... management , How to implement and manage those ...
(Date:9/19/2014)... Sept. 19, 2014 "Copay coupons," ... sales of brand drugs among patients with prescription drug ... to a new report  from the Department ... Inspector General (OIG). Federal anti-kickback laws prohibit suppliers ... are subsidized by the federal government. ...
Breaking Medicine Technology:Role of Medical Science Liaisons Shifting in Healthcare Industry 2In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2
... NxStage Medical, Inc. (Nasdaq: NXTM ), a leading ... its financial results for the third quarter ended September 30, ... of the financial markets. , NxStage will also host a ... 5, 2009 to discuss its third quarter financial results. To ...
... Conn., Oct. 15 AmeriCares has awarded its annual ... the largest health care products and services companies in ... the award today at the Healthcare Distribution Management Association,s ... Power of Partnership Award was created by AmeriCares and ...
Cached Medicine Technology:NxStage(R) to Report Third Quarter 2009 Financial Results 2AmeriCares Honors Cardinal Health with Power of Partnership Award 2AmeriCares Honors Cardinal Health with Power of Partnership Award 3
(Date:9/21/2014)... (PRWEB) September 21, 2014 Hundreds ... move forward in Pennsylvania’s Philadelphia Court of Common ... documents, the proceeding’s next monthly meeting has been ... number 100300296) , “Our Firm is representing a ... in this litigation. We are pleased with its ...
(Date:9/21/2014)... Dallas, Texas (PRWEB) September 21, 2014 ... Administration (FDA) in 1996, GSK’s Flovent (fluticasone propionate) ... activity. It is used for the maintenance treatment ... is now available in two formulations, Diskus and ... and 2004, respectively. Flovent’s active ingredient, fluticasone propionate, ...
(Date:9/21/2014)... An experienced review website in the global market, Top10BestSEOHosting.com, ... announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and Bluehost ... has been a boom in websites in recent years, ... in the number of web hosting companies that offer ... VPS (Virtual Private Server) is the method of partitioning ...
(Date:9/21/2014)... 2014 C8 lawsuits move forward in ... the list of 20 possible C8 lawsuits selected ... six, reports Wright & Schulte LLC. Court records show ... 2500 C8 lawsuits filed that represent individuals who purportedly ... a result of being exposed to water contaminated by ...
(Date:9/20/2014)... Diabetes Protocol , a breakthrough new ... thousands of people learn how to naturally manage and ... prescriptions has caught the attention of Shane Michaels, prompting ... of millions of people in the U.S. today who ... and unfortunately, big pharma makes a killing just by ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 4Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2
... Recovery for Many Facing Health CrisesCHICAGO, Jan. 15 Does ... challenges have found support and compassion through online communities such ... love is more than a dozen roses or candlelit dinner ... and defying the odds for survival. Just ask Lisa, ...
... information on its revamped website. AccessRx has provided tens of ... 1998. , ... (PRWEB) January 15, ... consumer information on its revamped website. AccessRx has provided tens ...
... Two radon-induced lung cancer survivors will be joined by ... Council Radon Awards Ceremony at the National Press ... the U.S. EPA, the ceremony is part of National ... and winners of the National Radon Poster Contest; but ...
... & Nephew,s Advanced Wound Management division (LSE: SN; NYSE: ... Court in the High Court of Justice of England and ... a temporary injunction prohibiting Smith & Nephew from commercializing foam ... Kingdom. The temporary injunction will remain in place until the ...
... Nationally; Many People May Not Realize They,re InfectedHARRISBURG, Pa., ... in the number of reported cases of gonorrhea and ... testing by men and women, according to the Department ... common bacterial sexually transmitted diseases is below the national ...
... with CorVel Corporation,s (Nasdaq: CRVL ) quarterly earnings release, CorVel will be ... 3rd at 11:30 am Eastern Time. , , Event: ... Dan Starck, President and CEO, ... Date: 11:30 am Eastern Time, Tuesday, ...
Cached Medicine News:Health News:More than Just a Box of Chocolates 2Health News:More than Just a Box of Chocolates 3Health News:AccessRx.com Launches Redesigned Website, Adds Content and Builds Online Community 2Health News:Radiation Victims to Rally In Washington - Demand Congressional Action to Protect Homebuyers; Organization Labels EPA's Radon Program a 'Deadly Failure' 2Health News:Radiation Victims to Rally In Washington - Demand Congressional Action to Protect Homebuyers; Organization Labels EPA's Radon Program a 'Deadly Failure' 3Health News:Smith & Nephew Advanced Wound Management Comments on Temporary Injunction in United Kingdom 2Health News:Smith & Nephew Advanced Wound Management Comments on Temporary Injunction in United Kingdom 3Health News:CorVel Corporation Announces Earnings Release Webcast 2
... Eliminate the need for makeshift, modified nebulizer ... waste time gathering parts when your patient ... to deliver the utmost in Heliox rescue ... is fast becoming the standard of care ...
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
... Entrainment Nebulizers deliver particulate humidity in the ... chronic secretion patients. For your convenience, Thera-Mist® ... supply of sterile water., ,The P30000N, ... of 20-50% with a total flow range ...
... For use with metered dose inhalers., ... aerosolized medication from MDI canisters. Its versatile ... a ventilator circuit, in conjunction with an ... routine, oral inhalation. ACE may also be ...
Medicine Products: